Gyre Therapeutics Ownership | Who Owns Gyre Therapeutics?


OverviewRevenueFinancialsChart

Gyre Therapeutics Ownership Summary


Gyre Therapeutics is owned by 9.69% institutional investors, 74.40% insiders, and 15.91% retail investors. Sc china is the largest institutional shareholder, holding 4.11% of GYRE shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 0.55% of its assets in Gyre Therapeutics shares.

GYRE Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockGyre Therapeutics9.69%74.40%15.91%
SectorHealthcare Stocks 50.50%12.33%37.17%
IndustryBiotech Stocks 49.09%12.06%38.85%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Sc china3.75M4.11%$24.71M
Vanguard group1.20M1.35%$8.48M
Blackrock funding, inc. /de993.94K1.09%$6.55M
Octagon capital advisors lp954.42K1.05%$6.29M
Vanguard capital management876.93K0.96%$5.78M
Geode capital management532.95K0.58%$3.51M
State street245.40K0.27%$1.62M
Sixth street partners management company184.29K0.20%$1.21M
Charles schwab investment management184.29K0.20%$1.21M
Northern trust169.54K0.19%$1.12M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Sc china3.75M2.06%$24.71M
Octagon capital advisors lp954.42K0.57%$6.29M
Sbi securities166.75K0.03%$1.10M
Polymer capital management (us)11.78K0.01%$77.63K
Aster capital management (difc)1.45K0.00%$10.63K
Activest wealth management533.000.00%$3.51K
Strs ohio25.80K0.00%$170.02K
Police & firemen's retirement system of new jersey9.01K0.00%$59.38K
Tower research capital llc (trc)2.47K0.00%$16.27K
State of alaska, department of revenue5.22K0.00%$34.00K

Top Buyers

HolderShares% AssetsChange
Sc china3.75M2.06%3.75M
Octagon capital advisors lp954.42K0.57%954.42K
Blackrock funding, inc. /de993.94K0.00%235.31K
Sixth street partners management company184.29K0.00%184.29K
Geode capital management532.95K0.00%101.54K

Top Sellers

HolderShares% AssetsChange
Vanguard capital management876.93K0.00%-107.28K
State of wisconsin investment board---24.80K
Brevan howard capital management lp---13.81K
Advantage alpha capital partners lp---13.66K
Verition fund management---13.35K

New Positions

HolderShares% AssetsChangeValue
Sc china3.75M2.06%3.75M$24.71M
Octagon capital advisors lp954.42K0.57%954.42K$6.29M
Sixth street partners management company184.29K0.00%184.29K$1.21M
Nuveen24.50K-24.50K$161.49K
Millennium management18.49K-18.49K$121.84K

Sold Out

HolderChange
Mai capital management-4.00
True wealth design-6.00
Massmutual trust co fsb/adv-12.00
Rise advisors-54.00
Advisory services network-66.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 20266110.91%8,851,089159.77%969.62%4540.63%8-27.27%
Mar 31, 20265425.58%3,407,2791.87%326.54%3124.00%1137.50%
Dec 31, 202510-78.26%1,417,139-54.22%113.18%3-87.50%3-78.57%
Sep 30, 202515-65.12%1,514,519-54.84%112.00%6-80.65%5-28.57%
Jun 30, 2025464.55%3,409,78030.67%341.97%3447.83%7-50.00%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard Total Stock Mkt Idx Inv614.65K0.55%-103.70K
Vanguard Morn Total Stk Mkt Idx Investor614.65K0.55%-103.70K
iShares Russell 2000 ETF385.81K0.35%-6.82K
Vanguard Institutional Extnd Mkt Idx Tr238.69K0.21%-
iShares Russell 2000 Growth ETF117.80K0.11%-1.08K
Fidelity Small Cap Index115.61K0.10%-160.00
Fidelity Extended Market Index111.08K0.10%-160.00
Vanguard Russell 2000 ETF104.61K0.09%44.51K
Schwab US Small-Cap ETF™99.02K0.09%-
Russell 2000 Equity Index Fund B87.26K0.08%215.00

Recent Insider Transactions


DateNameRoleActivityValue
Jun 10, 2026Ye Weiguo Chief Operating OfficerSell$31.20K
Jun 09, 2026Ye Weiguo Chief Operating OfficerSell$18.45K
Jun 18, 2026Ye Weiguo Chief Operating OfficerSell$19.05K
Jun 11, 2026Ye Weiguo Chief Operating OfficerSell$17.28K
Jun 09, 2026Ye Weiguo Chief Operating OfficerSell$89.03K

Insider Transactions Trends


DateBuySell
2026 Q3--
2026 Q2-17
2026 Q1--
2025 Q3--
2025 Q2-12

GYRE Ownership FAQ


Who Owns Gyre Therapeutics?

Gyre Therapeutics shareholders are primarily institutional investors at 9.69%, followed by 74.40% insiders and 15.91% retail investors. The average institutional ownership in Gyre Therapeutics's industry, Biotech Stocks , is 49.09%, which Gyre Therapeutics falls below.

Who owns the most shares of Gyre Therapeutics?

Gyre Therapeutics’s largest shareholders are Sc china (3.75M shares, 4.11%), Vanguard group (1.2M shares, 1.35%), and Blackrock funding, inc. /de (993.94K shares, 1.09%). Together, they hold 6.54% of Gyre Therapeutics’s total shares outstanding.

Does Blackrock own Gyre Therapeutics?

BlackRock is not among the top 10 institutional shareholders of Gyre Therapeutics.

Who is Gyre Therapeutics’s biggest shareholder by percentage of total assets invested?

Sc china is Gyre Therapeutics’s biggest shareholder by percentage of total assets invested, with 2.06% of its assets in 3.75M Gyre Therapeutics shares, valued at 24.71M$.

Who is the top mutual fund holder of Gyre Therapeutics shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Gyre Therapeutics shares, with 0.55% of its total shares outstanding invested in 614.65K Gyre Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools